Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Notch signalling regulates stem cell numbers in vitro and in vivo
Solubility: DMSO: 56 mg/mL(201
Formula: C15H16N2O
6-naphthyridin-2-yl}cyclopropyl]-[1
Linagliptin Catalog No.:M10654-10 Notch signalling regulates stem cellLinagliptin, also known as BI 1356, is a DPP 4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes. Linagliptin (once daily) was approved by the US FDA on 2 May 2011 for treatment of type II diabetes. It is being marketed by Boehringer Ingelheim and Lilly. Product information CAS Number: 668270 12 0 Molecular Weight: 472. 54 Formula: C25H28N8O2 Chemical Name: 8 [(3R) 3 aminopiperidin 1 yl] 7 (but 2 yn 1 yl) 3 methyl 1 [(4
US$ 1442.50
US$ 20.00
US$ 792.50
US$ 392.50
US$ 142.50
US$ 16.00
US$ 742.50
US$ 192.50
US$ 292.50
US$ 142.50
US$ 892.50
US$ 28.00
US$ 192.50
US$ 50.00
US$ 742.50
US$ 50.00